The increasing occurrence of antibiotic-resistant bacteria and the dwindling antibiotic research and development pipeline have created a pressing global health crisis. Here, we report the discovery of a distinctive antibacterial therapy that uses visible (405 nanometers) light-activated synthetic molecular machines (MMs) to kill Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus , in minutes, vastly outpacing conventional antibiotics. MMs also rapidly eliminate persister cells and established bacterial biofilms. The antibacterial mode of action of MMs involves physical disruption of the membrane. In addition, by permeabilizing the membrane, MMs at sublethal doses potentiate the action of conventional antibiotics. Repeated exposure to antibacterial MMs is not accompanied by resistance development. Finally, therapeutic doses of MMs mitigate mortality associated with bacterial infection in an in vivo model of burn wound infection. Visible light–activated MMs represent an unconventional antibacterial mode of action by mechanical disruption at the molecular scale, not existent in nature and to which resistance development is unlikely.
Multidrug-resistance in pathogenic bacteria is an increasing problem in patient care and public health. Molecular nanomachines (MNM) have the ability to open cell membranes using nanomechanical action. We hypothesized that MNM could be used as antibacterial agents by drilling into bacterial cell walls and increasing susceptibility of drug resistant bacteria to recently ineffective antibiotics. We exposed extensively drug resistant K. pneumoniae to light-activated MNM and found that MNM increase susceptibility to meropenem. MNM with meropenem can effectively kill K. pneumoniae that are considered meropenem resistant. We examined the mechanisms of MNM action using permeability assays and transmission electron microscopy, finding that MNM disrupt the cell wall of extensively drug resistant K. pneumoniae, exposing the bacteria to meropenem. These observations suggest that MNM could be used to make conventional antibiotics more efficacious against multidrug-resistant pathogens.